🎁 Black Friday: up to 50% off of annual plans
Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
0.7113
-0.0371 (-4.96%)
At close: Nov 20, 2026, 4:00 PM EST
0.7300
+0.0187 (2.63%)
After-hours: Nov 20, 2026, 7:53 PM EST

Annovis Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-28.85-24.59-56.2-25.33-14.49
Stock-Based Compensation
1.83.844.639.154.7
Other Operating Activities
-0.14-1.8211.84--
Change in Accounts Payable
0.281.01-2.673.270.35
Change in Other Net Operating Assets
1.29-0.332.44-4.410.31
Operating Cash Flow
-25.62-21.89-39.97-17.31-9.13
Operating Cash Flow Growth
-----

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
34.626.6917.34046.74
Financing Cash Flow
34.626.6917.34046.74

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
8.984.8-22.62-17.3137.61

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-15.18-12.17-23.75-7.93-3.73
Unlevered Free Cash Flow
-15.18-12.17-23.75-7.93-3.73

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
1.580.68-0.23-1.140.66
SEC Filings: 10-K · 10-Q